Proportion with a serious adverse event · lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
PainScale: VAS (0 to 10, 0 is no pain) · lateral elbow pain
1 finding from 1 review
DisabilityScale: 0 to 100 (0 is no disability) · lateral elbow pain
1 finding from 1 review
Death · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
End‐of‐treatment response · patients on HD with HCV infection
Direct antivirals (grazoprevir and elbasvir) may leads to higher end‐of‐treatment response compared with placebo (low certainty).
1 finding from 1 review
Sustained virological response · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment discontinuation · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Smoking cessation · people who smoke
Preloading nicotine replacement therapy (NRT) probably leads to higher smoking cessation compared with standard‐use NRT (moderate certainty).
1 finding from 1 review
Overall serious adverse events · people who smoke
Preloading nicotine replacement therapy (NRT) showed no clear difference in overall serious adverse events compared with standard‐use NRT (low certainty).
1 finding from 1 review
Treatment withdrawal · people who smoke
It is very uncertain whether preloading nicotine replacement therapy (NRT) changes treatment withdrawals compared with standard‐use NRT (very low certainty).
1 finding from 1 review
Pain score · women having medical abortion before 14 weeks' gestation
1 finding from 1 review
Nausea · women having medical abortion before 14 weeks' gestation
Summary of findings table ‐ Pregabalin 300 mg showed no clear difference in gastrointestinal side effects (nausea) compared with placebo (low certainty).
1 finding from 1 review
Vomiting · women having medical abortion before 14 weeks' gestation
Summary of findings table ‐ Pregabalin 300 mg showed no clear difference in gastrointestinal side effects (vomiting) compared with placebo (low certainty).
1 finding from 1 review
Diarrhoea · women having medical abortion before 14 weeks' gestation
Summary of findings table ‐ Pregabalin 300 mg showed no clear difference in gastrointestinal side effects (diarrhoea) compared with placebo (low certainty).
1 finding from 1 review
Complete abortion rate ‐ not reported · women having medical abortion before 14 weeks' gestation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Induction to expulsion interval ‐ not reported · women having medical abortion before 14 weeks' gestation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Unscheduled contact with care ‐ not reported · women having medical abortion before 14 weeks' gestation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient satisfaction with analgesia ‐ not reported · women having medical abortion before 14 weeks' gestation
Summary of findings table ‐ Pregabalin 300 mg showed no clear difference in patient satisfaction with analgesia compared with placebo (low certainty).
1 finding from 1 review